William Gething Crawford, MD | |
21 Montauk Ave Ste 303, New London, CT 06320-4906 | |
(869) 442-4878 | |
(860) 447-8845 |
Full Name | William Gething Crawford |
---|---|
Gender | Male |
Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
Location | 21 Montauk Ave Ste 303, New London, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114019098 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0129X | Surgery - Vascular Surgery | 023948 (Connecticut) | Primary |
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 023948 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
William Gething Crawford, MD 21 Montauk Ave Ste 303, New London, CT 06320-4906 Ph: (869) 442-4878 | William Gething Crawford, MD 21 Montauk Ave Ste 303, New London, CT 06320-4906 Ph: (869) 442-4878 |
News Archive
Last month more than 250,000 personalized leaflets were sent out to women with a warning that a Conservative government would scrap a Labour guarantee that all suspected breast cancer patients would be seen by a specialist within two weeks of GP referral. They also claimed that the Conservative party will take away the right to be treated for cancer within 18 weeks. According to a Sunday Times report some of the recipients of this leaflet were cancer patients or cancer survivors.
Bose Corporation has introduced the 3DCulturePro™ system, a new multi-specimen perfusion bioreactor designed for biologists, biomedical researchers and scientists who require reproducible and reliable tissue growth. The 3DCulturePro system supports cell growth and 3D tissue culture in an easy-to-use, scalable configuration.
About 26% percent of the American workforce, including health-care workers and sanitation staff, need to work night shifts. Earlier research has shown that regular night shifts may disrupt the circadian rhythm, raising the risk of heart disease, obesity, ulcers and even depression.
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.
A new study shows as many as one in 20 children were still receiving codeine to treat pain after tonsil and adenoid surgery, two years after federal regulators warned doctors that prescribing the opioid to kids after the routine surgeries could be fatal.
› Verified 8 days ago